• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

洛杉矶分类联合食管黏膜血红蛋白指数可预测糜烂性反流性食管炎的治疗应答。

Supplementation of Los Angeles classification with esophageal mucosa index of hemoglobin can predict the treatment response of erosive reflux esophagitis.

机构信息

Department of Internal Medicine, National Cheng Kung University Medical Center, 138 Sheng Li Road, Tainan, 70428, Taiwan, ROC.

出版信息

Surg Endosc. 2011 Aug;25(8):2478-86. doi: 10.1007/s00464-010-1569-x. Epub 2011 Feb 7.

DOI:10.1007/s00464-010-1569-x
PMID:21298521
Abstract

BACKGROUND

We assessed whether the esophageal mucosa index of hemoglobin (IHb) could assist the Los Angeles (LA) classification in defining the severity of erosive reflux esophagitis (RE) and predicting the treatment response by esomeprazole.

METHODS

Five hundred twenty-four subjects (424 RE and 100 controls) with normal body mass index and hemoglobin had undergone endoscopy to confirm the RE grade by LA classification and to check the series of IHb values at every centimeter of the esophageal mucosa while withdrawing the endoscope to above the esophageal-gastric junction (EGJ). The RE cases had received esomeprazole for 8 weeks (40 mg/day) to assess the cumulative proportions of sustained symptomatic response (SSR).

RESULTS

The IHb value at the EGJ was higher in RE patients than in controls (P < 0.001). Selecting 70 as the cutoff IHb value at the EGJ, the efficacy to define RE achieved 95.8% (406/424) sensitivity and 94% (94/100) specificity. For the patients with same the LA grade, the length of IHb value >70 above the EGJ (L-IHb70) that is greater than 4 cm correlated with a poor cumulative rate of SSR (P < 0.01).

CONCLUSION

The IHb value >70 at the EGJ is a reliable indicator of RE. The L-IHb70 can serve as a supplementary indicator to predict the response to esomeprazole index within the same LA grade.

摘要

背景

我们评估了血红蛋白食管黏膜指数(IHb)是否可以帮助洛杉矶(LA)分类定义侵蚀性反流性食管炎(RE)的严重程度,并通过埃索美拉唑预测治疗反应。

方法

524 名(424 名 RE 和 100 名对照)具有正常体重指数和血红蛋白的受试者接受内镜检查,通过 LA 分类确认 RE 等级,并在退出内镜至食管胃交界处(EGJ)上方时检查食管黏膜每厘米的一系列 IHb 值。RE 病例接受埃索美拉唑治疗 8 周(40mg/天),以评估持续症状缓解(SSR)的累积比例。

结果

RE 患者的 EGJ 处的 IHb 值高于对照组(P <0.001)。选择 70 作为 EGJ 处的 IHb 截断值,对 RE 的定义效果达到 95.8%(406/424)的敏感性和 94%(94/100)的特异性。对于具有相同 LA 等级的患者,EGJ 上方 IH70 长度(L-IHb70)大于 4cm 与 SSR 累积率差相关(P <0.01)。

结论

EGJ 处的 IHb 值>70 是 RE 的可靠指标。L-IHb70 可以作为预测同一 LA 等级内埃索美拉唑指数反应的补充指标。

相似文献

1
Supplementation of Los Angeles classification with esophageal mucosa index of hemoglobin can predict the treatment response of erosive reflux esophagitis.洛杉矶分类联合食管黏膜血红蛋白指数可预测糜烂性反流性食管炎的治疗应答。
Surg Endosc. 2011 Aug;25(8):2478-86. doi: 10.1007/s00464-010-1569-x. Epub 2011 Feb 7.
2
The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis.体重指数对洛杉矶A级和B级反流性食管炎按需治疗应用的影响。
Am J Gastroenterol. 2007 Nov;102(11):2387-94. doi: 10.1111/j.1572-0241.2007.01468.x.
3
Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole.体重指数可确定埃索美拉唑治疗洛杉矶分级为C级和D级的反流性食管炎的愈合情况。
Am J Gastroenterol. 2008 Sep;103(9):2209-14. doi: 10.1111/j.1572-0241.2008.01979.x. Epub 2008 Aug 12.
4
Healing of Erosive Esophagitis and Improvement of Symptoms of Gastroesophageal Reflux Disease After Esomeprazole Treatment in Children 12 to 36 Months Old.12至36个月大儿童接受埃索美拉唑治疗后糜烂性食管炎的愈合及胃食管反流病症状的改善
J Pediatr Gastroenterol Nutr. 2015 Jul;60 Suppl 1:S31-6. doi: 10.1097/MPG.0b013e3181ddcf11.
5
On-demand therapy for Los Angeles grade A and B reflux esophagitis: esomeprazole versus omeprazole.洛杉矶A级和B级反流性食管炎的按需治疗:埃索美拉唑与奥美拉唑对比
J Formos Med Assoc. 2003 Sep;102(9):607-12.
6
Clinical and endoscopic evaluation of gastroesophageal reflux disease in patients successfully treated with esomeprazole.使用埃索美拉唑成功治疗的胃食管反流病患者的临床和内镜评估
Arq Gastroenterol. 2003 Oct-Dec;40(4):262-7. doi: 10.1590/s0004-28032003000400012. Epub 2004 May 31.
7
Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study.埃索美拉唑治疗儿童糜烂性食管炎:一项国际性、多中心、随机、平行分组、双盲(针对剂量)研究。
BMC Pediatr. 2010 Jun 11;10:41. doi: 10.1186/1471-2431-10-41.
8
Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.在 12 至 36 个月大的儿童中,埃索美拉唑治疗后可治愈糜烂性食管炎并改善胃食管反流病的症状。
J Pediatr Gastroenterol Nutr. 2010 Nov;51(5):593-8. doi: 10.1097/MPG.0b013e3181ddcf11.
9
Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy.微小变化性食管炎:使用放大内镜对非糜烂性反流病患者与正常对照者的内镜和组织学标志物进行前瞻性比较。
Dig Dis. 2004;22(2):221-7. doi: 10.1159/000080323.
10
Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.埃索美拉唑(40毫克)与兰索拉唑(30毫克)治疗糜烂性食管炎的比较。
Am J Gastroenterol. 2002 Mar;97(3):575-83. doi: 10.1111/j.1572-0241.2002.05532.x.

引用本文的文献

1
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis.风险因素与 1997 年至 2022 年 26 年间全球范围内内镜下侵蚀性食管炎的患病率:一项荟萃分析。
Sci Rep. 2023 Sep 14;13(1):15249. doi: 10.1038/s41598-023-42636-7.

本文引用的文献

1
Double-dosed pantoprazole accelerates the sustained symptomatic response in overweight and obese patients with reflux esophagitis in Los Angeles grades A and B.双倍剂量泮托拉唑可加速超重和肥胖的洛杉矶 A 和 B 级反流性食管炎患者的持续症状缓解。
Am J Gastroenterol. 2010 May;105(5):1046-52. doi: 10.1038/ajg.2009.632. Epub 2009 Nov 10.
2
H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.幽门螺杆菌根除可预防反流性食管炎患者使用长期埃索美拉唑后胃小肠化生的进展。
Am J Gastroenterol. 2009 Jul;104(7):1642-9. doi: 10.1038/ajg.2009.172. Epub 2009 May 12.
3
Body mass index can determine the healing of reflux esophagitis with Los Angeles Grades C and D by esomeprazole.
体重指数可确定埃索美拉唑治疗洛杉矶分级为C级和D级的反流性食管炎的愈合情况。
Am J Gastroenterol. 2008 Sep;103(9):2209-14. doi: 10.1111/j.1572-0241.2008.01979.x. Epub 2008 Aug 12.
4
The impact of body mass index on the application of on-demand therapy for Los Angeles grades A and B reflux esophagitis.体重指数对洛杉矶A级和B级反流性食管炎按需治疗应用的影响。
Am J Gastroenterol. 2007 Nov;102(11):2387-94. doi: 10.1111/j.1572-0241.2007.01468.x.
5
Analysis of endoscopic electronic image of intramucosal gastric carcinoma using a software program for calculating hemoglobin index.使用血红蛋白指数计算软件程序对胃黏膜内癌的内镜电子图像进行分析。
J Korean Med Sci. 2006 Dec;21(6):1041-7. doi: 10.3346/jkms.2006.21.6.1041.
6
Persistence and adherence to proton pump inhibitors in daily clinical practice.日常临床实践中质子泵抑制剂的持续性和依从性
Aliment Pharmacol Ther. 2006 Jul 15;24(2):377-85. doi: 10.1111/j.1365-2036.2006.02982.x.
7
Techniques using the hemoglobin index of the gastric mucosa.使用胃黏膜血红蛋白指数的技术。
Endoscopy. 2005 May;37(5):479-86. doi: 10.1055/s-2005-861285.
8
Adaptive index of hemoglobin color enhancement for the diagnosis of colorectal disease.用于结直肠疾病诊断的血红蛋白颜色增强自适应指数。
Endoscopy. 2005 Apr;37(4):386-8. doi: 10.1055/s-2005-861094.
9
Esomeprazole 40 mg twice daily in triple therapy and the efficacy of Helicobacter pylori eradication related to CYP2C19 metabolism.埃索美拉唑40毫克,每日两次,用于三联疗法以及与CYP2C19代谢相关的幽门螺杆菌根除疗效。
Aliment Pharmacol Ther. 2005 Feb 1;21(3):283-8. doi: 10.1111/j.1365-2036.2005.02281.x.
10
Relationship between histopathologic gastritis and mucosal microvascularity: observations with magnifying endoscopy.组织病理学胃炎与黏膜微血管之间的关系:放大内镜观察
Gastrointest Endosc. 2003 Jul;58(1):71-5. doi: 10.1067/mge.2003.316.